全文获取类型
收费全文 | 8073篇 |
免费 | 356篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 89篇 |
儿科学 | 226篇 |
妇产科学 | 136篇 |
基础医学 | 1244篇 |
口腔科学 | 102篇 |
临床医学 | 668篇 |
内科学 | 1884篇 |
皮肤病学 | 258篇 |
神经病学 | 940篇 |
特种医学 | 393篇 |
外科学 | 1064篇 |
综合类 | 63篇 |
一般理论 | 1篇 |
预防医学 | 263篇 |
眼科学 | 263篇 |
药学 | 501篇 |
中国医学 | 9篇 |
肿瘤学 | 359篇 |
出版年
2023年 | 25篇 |
2022年 | 86篇 |
2021年 | 139篇 |
2020年 | 81篇 |
2019年 | 137篇 |
2018年 | 153篇 |
2017年 | 128篇 |
2016年 | 141篇 |
2015年 | 180篇 |
2014年 | 254篇 |
2013年 | 320篇 |
2012年 | 510篇 |
2011年 | 498篇 |
2010年 | 320篇 |
2009年 | 289篇 |
2008年 | 464篇 |
2007年 | 522篇 |
2006年 | 520篇 |
2005年 | 499篇 |
2004年 | 466篇 |
2003年 | 484篇 |
2002年 | 430篇 |
2001年 | 87篇 |
2000年 | 49篇 |
1999年 | 65篇 |
1998年 | 99篇 |
1997年 | 89篇 |
1996年 | 60篇 |
1995年 | 49篇 |
1994年 | 62篇 |
1993年 | 48篇 |
1992年 | 39篇 |
1991年 | 37篇 |
1990年 | 34篇 |
1989年 | 32篇 |
1988年 | 32篇 |
1987年 | 24篇 |
1985年 | 23篇 |
1983年 | 30篇 |
1982年 | 24篇 |
1981年 | 28篇 |
1980年 | 29篇 |
1978年 | 24篇 |
1937年 | 24篇 |
1936年 | 23篇 |
1935年 | 27篇 |
1933年 | 23篇 |
1931年 | 28篇 |
1930年 | 26篇 |
1925年 | 23篇 |
排序方式: 共有8463条查询结果,搜索用时 0 毫秒
61.
62.
Senderek J Hermanns B Lehmann U Bergmann C Marx G Kabus C Timmerman V Stoltenburg-Didinger G Schröder JM 《Brain pathology (Zurich, Switzerland)》2000,10(2):235-248
Mutations in the gene for the major protein component of peripheral nerve myelin, myelin protein zero (MPZ, P0), cause hereditary disorders of Schwann cell myelin such as Charcot-Marie-Tooth neuropathy type 1B (CMT1B), Dejerine-Sottas syndrome (DSS), and congenital hypomyelinating neuropathy (CHN). More recently, P0 mutations were identified in the axonal type of CMT neuropathy, CMT2, which is different from the demyelinating variants with respect to electroneurography and nerve pathology. We screened 49 patients with a clinical and histopathological diagnosis of CMT2 for mutations in the P0 gene. Three heterozygous single nucleotide changes were detected: two novel missense mutations, Asp61Gly and Tyr119Cys, and the known Thr124Met substitution, that has already been reported in several CMT patients from different European countries. Haplotype analysis for the P0 locus proved that our patients with the 124Met allele were not related to a cohort of patients with the same mutation, all of Belgian descent and all found to share a common ancestor. Our data suggest that P0 mutations account for a detectable proportion of CMT2 cases with virtually every patient harbouring a different mutation but recurrence of the Thr124Met amino acid substitution. The high frequency of this peculiar genotype in the European CMT population is presumably not only due to a founder effect but Thr124Met might constitute a mutation hotspot in the P0 gene as well. 相似文献
63.
64.
Biallelic somatic inactivation of the mismatch repair gene MLH1 in a primary skin melanoma 总被引:2,自引:0,他引:2
Castiglia D Pagani E Alvino E Vernole P Marra G Cannavò E Jiricny J Zambruno G D'Atri S 《Genes, chromosomes & cancer》2003,37(2):165-175
Inactivation of mismatch repair (MMR) genes has been linked to the hereditary nonpolyposis colon cancer syndrome and to a subset of sporadic cancers. A phenotypic characteristic of tumors with defective MMR is microsatellite instability (MSI). Although MSI has been reported in a proportion of cutaneous melanomas, inactivation of MMR genes in this tumor type has not been detected thus far. We recently described a human melanoma cell line, PR-Mel, and a cutaneous metastasis from the same patient, which displayed a MMR defect, and showed high MSI. Here we report that in the PR-Mel cell line both MLH1 alleles are somatically inactivated. One allele is lost through a chromosomal deletion of the region 3p21-24, whereas the remaining allele harbors a G --> A transition at position -1 of the acceptor splice site of intron 15, leading to the in-frame skipping of exon 16. The primary melanoma of the PR patient shows loss of heterozygosity at the BAT21 microsatellite marker, located in the MLH1 gene, and does not express the MLH1 and PMS2 proteins. Moreover, it harbors the same mutation detected in the PR-Mel cells. These results demonstrate that biallelic inactivation of MLH1 had occurred in the primary melanoma of the PR patient and suggest that disruption of MMR might have had a role in the development of the melanoma. This is the first report in which genetic defects leading to disruption of MMR function in a human melanoma have been identified. 相似文献
65.
Pancreatic mucinous noncystic (colloid) carcinomas and intraductal papillary mucinous carcinomas are usually microsatellite stable. 总被引:4,自引:0,他引:4
Jutta Lüttges Kurt Beyser Susanne Pust Anja Paulus Josef Rüschoff Günter Kl?ppel 《Modern pathology》2003,16(6):537-542
Pancreatic mucinous noncystic (colloid) carcinomas (MNCC) differ from the usual ductal adenocarcinomas in their mucin expression profile and share with many extrapancreatic mucinous carcinomas the expression of MUC2. Because mucinous carcinomas are frequently associated with mutations of the DNA mismatch repair genes, causing them to exhibit the so-called mutator phenotype, we decided to investigate whether MNCCs of the pancreas are characterized by microsatellite instability (MSI). Twelve carcinomas with a mucinous phenotype (8 mucinous noncystic carcinomas, 3 intraductal papillary-mucinous carcinomas with an invasive muconodular component, and 1 ductal adenocarcinoma with an extensive mucinous noncystic component) and 11 ductal adenocarcinomas were immunostained with monoclonal antibodies to the mismatch repair gene products hMLH1, hMSH2, and hMSH6. For MSI analysis, DNA was isolated from microdissected tissue, and five primary microsatellites (BAT 25, BAT 26, D5S346, D17S250, and D2S123) were analyzed. MSI was diagnosed in case a novel allele was found, compared with the normal tissue. The criterion for LOH was a 75% signal reduction. All carcinomas tested exhibited nuclear expression of mismatch repair gene products, except for one MNCC that also showed MSI at the molecular level. The data suggest that pancreatic carcinomas with a mucinous phenotype (MUC2+/MUC1-) do not appear to normally exhibit mutations in the mismatch repair genes and therefore differ in their carcinogenesis from those in other organs. 相似文献
66.
67.
Sevelová L Vachek J 《Acta medica (Hradec Králové) / Universitas Carolina, Facultas Medica Hradec Králové》2003,46(3):109-112
The effect of methoxime combined with a) atropine, b) benactyzine, c) atropine and natrium thiosulphate, d) atropine and diazepam on antidotal treatment effectiveness was studied in tabun-poisoned mice. In addition, the influence of pretreatment consisiting of pyridostigmine, benactyzine and trihexyphenidyle (PANPAL) administered 2 hours before tabun intoxication on the treatment effectivity of methoxime combined with e) atropine or f) benactyzine was tested. The most efficacious therapeutic mixture in non-pretreated mice was methoxime, atropine and diazepam. Natrium thiosulphate did not significantly increase neither decrease the antidotal treatment efficacy in comparison with methoxime and atropine alone. Pretreatment with PANPAL significantly decreased tabun toxicity (nearly 4 times in methoxime and benactyzine combination and more than 4 times in atropine and methoxime mixture). The present study demonstrates that the tabun toxicity in mice is more effectively reduced when PANPAL prophylactically is administered than in case of treatment with methoxime and cholinergic drug alone. We established that anticholinergic drug option in the therapeutic mixture of methoxime and anticholinergic drug did not cause the difference in the antidotal treatment effectivities. 相似文献
68.
Andrew J. Carroll Robert P. Castleberry Josef T. Prchal Wayne H. Finley 《Cancer Genetics and Cytogenetics》1985,18(4):303-306
Several recent reports have described cases of acute nonlymphocytic leukemia with a unique chromosome translocation, t(6;9)(p23;q34). We have studied three additional patients who have acute nonlymphocytic leukemia and t(6;9)(p23;q34). Our findings provide additional support for the suggestion that this translocation is yet another distinct cytogenetic abnormality associated with myeloproliferative disorders. 相似文献
69.
Bohdan Schneider Jan tokr Jií Spv
ek Josef Baldrian 《Macromolecular chemistry and physics.》1987,188(11):2705-2711
Infrared spectra of partially crystalline and amorphous samples of isotactic poly(methyl methacrylate) (i-PMMA), poly[methyl (α,α,α-2H3)methacrylate] (i-PMMA-α-CD3), poly-[(2H3)methyl methacrylate] (i-PMMA-OCD3), and poly[(2H3)methyl (α,α,α,2,2-2H5)methacrylate] (i-PMMA-D8) were measured. Infrared spectra of the pure crystalline forms of these substances were obtained by digital separation. It was found that in acetonitrile, CDCl3, and toluene solutions, i-PMMA has the same conformational structure as in the amorphous state; conformational structures of crystalline i-PMMA are not present in the solutions in measurable amounts. 相似文献
70.
Eva-Bettina Brcker Ludwig Suter Josef Brüggen Dirk J. Ruiter Egon Macher Clemens Sorg 《International journal of cancer. Journal international du cancer》1985,36(1):29-35
The phenotypic changes in human melanoma cells during the course of tumor progression were studied with monoclonal antibodies (MAbs) against the melanoma-associated antigens (MAA) M.2.2.4, H.2.8.10, K.1.2, A.1.43, and A.10.33, and HLA-(A,B,C and D). Cryostat sections of 172 primary melanomas of the skin, 157 melanoma metastases and 56 nevi were investigated with an indirect immunoperoxidase method. Phenotypic heterogeneity was observed within lesions at all stages, and also within different tumors of the same patients. Despite this heterogeneity, principles of antigen expression were found. From the reaction pattern of MAbs, the following classifications of antigens were derived: "constitutive" markers of nevomelanocytic cells (M.2.2.4 and H.2.8.10) were found expressed over a wide range of local and systemic tumors. One MAA, K.1.2 (Suter et al., 1985), that declines with progression of melanoma, was classified as an "early" antigen, whereas MAA that appear in primary melanoma in proportion to invasiveness, and which are expressed in metastases of lymph nodes and visceral organs (A.1.43, and A.10.33), were classified as "late" markers of tumor progression. HLA-antigens were classified as "intermediate" markers, HLA-A,B,C, as an "early-intermediate", and HLA-DR as a "late-intermediate" marker. The occurrence of class II HLA, A.1.43-, and A.10.33-positive tumor cells in primary melanoma indicates a high metastatic potential of tumors, independent of tumor thickness. The data show that local and systemic progression of melanoma is associated with qualitative changes in tumor cells which can be recognized by MAbs. 相似文献